Kodikaz website
Atlanta, US · 3 known investors
Kodikaz develops Zip-Code, a non-viral cell-specific delivery platform for gene therapy applications, particularly focused on oncology and cancer treatments. The company serves oncologists and patients with cancer seeking advanced therapeutic solutions.